North Central Cancer Treatment Group

Protocol Specific Forms for /N0572/Correspondence

	                                                    Last
	Name                                                Modified   Size

	CCI-779 Action Letter_05Sep2008.pdf                 9/4/2008   3291k
	EligibilityMemo_06Nov2009.pdf                       10/29/2009 35k
	EligibilityMemo_28Sep2011.pdf                       9/28/2011  26k
	FormsMemo_05May2009.pdf                             5/4/2009   27k
	FormsMemo_07Jan2011.pdf                             12/21/2010 33k
	FormsMemo_24Apr2009.pdf                             4/20/2009  35k
	FormsMemo_26Dec2008.pdf                             12/8/2008  35k
	FormsMemo_28Jan2011.pdf                             1/19/2011  32k
	Memo_06Jul2007.pdf                                  6/20/2007  26k
	Memo_08Sep2006.pdf                                  9/5/2006   26k
	Memo_13Jul2007.pdf                                  7/16/2007  35k
	Memo_14Apr2006.pdf                                  4/11/2006  26k
	Memo_23Jun2006.pdf                                  6/22/2006  27k
	Memo_24Mar2006.pdf                                  3/22/2006  27k
	Memo_27Jul2007.pdf                                  7/26/2007  35k
	NCCTGMemo_07Jan2011.pdf                             1/4/2011   27k
	PfizerMemo_29Dec2010.pdf                            2/2/2011   36k
	Sorafenib (BAY 43-9006)_ActionLetter_12Feb2009.pdf  2/16/2009  2092k
	SpecimenCollectionMemo_12Nov2010.pdf                11/10/2010 28k
	ToriselMemo_04Feb2011.pdf                           2/2/2011   27k
	ToriselMemo_ProtMail_04Feb2011.pdf                  2/2/2011   56k